Caribou Biosciences, Inc. (CRBU) vs Genelux Corporation (GNLX)
A side-by-side comparison of Caribou Biosciences, Inc. and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
GNLX
Genelux Corporation
$2.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRBU vs GNLX
growth of $100 · dividends reinvested · last 4yCRBU -82.9% (-35.7%/yr)GNLX -57.7% (-19.4%/yr)GNLX compounded faster over this window
CRBU GNLX
CRBU vs GNLX: by the numbers
- •GNLX is the larger company ($114M vs $113M market cap).
- •Both run net losses; CRBU's is the smaller (-1030.42% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | CRBU | GNLX |
|---|---|---|
| P/S ratio | 11.22 | 14236.83 |
| P/B ratio | 1.15 | 7.07 |
Profitability
| Metric | CRBU | GNLX |
|---|---|---|
| Gross margin | 67.34% | -7075.00% |
| Operating margin | -1220.49% | -415175.00% |
| Net margin | -1030.42% | -422412.50% |
| ROE | -105.40% | -209.73% |
| ROIC | -87.72% | -192.18% |
Growth (annualized)
| Metric | CRBU | GNLX |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.